Related Experiment Video
Updated: May 18, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Abdominoperineal extralevator resection
Mattias Prytz1, Eva Angenete, Eva Haglind
1Department of surgery, NU-hospital group, S-461 85, Trollhättan, Sweden. mattias.prytz@vgregion.se
Danish Medical Journal
|September 7, 2012
Summary
Extralevator abdominoperineal resection (eAPR) may improve outcomes for distal rectal cancer patients. This registry study compares eAPR to standard abdominoperineal resection (APR) regarding local recurrence and quality of life.
Area of Science:
- Colorectal surgery
- Surgical oncology
- Patient outcomes research
Background:
- Abdominoperineal resection (APR) for distal rectal cancer has high recurrence rates.
- Extralevator abdominoperineal resection (eAPR) is a novel, more extensive surgical approach.
- Limited data exists on the oncological and functional impact of eAPR.
Purpose of the Study:
- To compare local recurrence rates between APR and eAPR.
- To evaluate functional and quality-of-life outcomes after APR versus eAPR.
- To assess the impact of surgical technique on distal rectal cancer treatment.
Main Methods:
- Registry-based study of all Swedish patients undergoing APR or eAPR (2007-2009).
- Prospective assessment of local recurrence rates at three years postoperatively.
- Evaluation of functional and quality-of-life outcomes 3-4 years postoperatively.
Main Results:
- Data on local recurrence rates for APR vs. eAPR will be presented.
- Functional outcomes and quality of life data will be analyzed.
- The study provides population-based evidence on surgical technique impact.
Conclusions:
- Distal rectal cancer presents significant surgical and oncological challenges.
- The APER study will compare oncological and functional outcomes of APR and eAPR.
- This research aims to guide surgical practice for improved patient prognosis.
